Full Length Research Paper
References
|
Abdelmegeed E, Shaaban MI (2013). Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans. J. Microbiol. 51(5):598-604. |
|
|
Alem M A, Douglas L J (2005). Prostaglandin production during growth of Candida albicans biofilms. J. Med. Microbiol. 54:1001-1005. |
|
|
Ashraf A, Yousri F, Taha N, Abd El-Waly O, Ramadan A, Ismail E (2015). Effect of Some Non-steroidal Anti-Inflammatory Drugs on Growth, Adherence and Mature Biofilms of Candida spp. Am. J. Microbiol. Res. 3(1):1-7. |
|
|
Auphan N, Di Donato J A, Rosette C, Helmerg A, Karin M (1995). Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290. |
|
|
Benyahya M, Senaud J, Bohatier J (1992). Etude en microscopie électronique. Ann. Sci. Nat. 13:103-119. |
|
|
Biswas S, Van Dijck P, Datta A (2007). Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol. Mol. Biol. Rev. 71:348-376. |
|
|
Brooks PM, Day RO (1991). Non-steroidal anti-inflammatory drugs–differences and similarities. New Engl. J. Med. 324:1716–125. |
|
|
CLSI-Clinical and Laboratory Standards Institute (2008). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A7. 7 edition. Wayne, PA: CLSI. |
|
|
Cox SD, Mann CM, Markham JL, Bell HC, Gustafson JE, Warmington JR, Wyllie SG (2000). The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tree oil). J. Appl. Microbiol. 88:170-175. |
|
|
Crump JA, Collignon PJ (2000). Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 19:1-8. |
|
|
Ding X, Liu Z, Su J, Yan D (2014). Human serum inhibits adhesion and biofilm formation in Candida albicans. BMC Microbiol. 14:80. |
|
|
Dominic RM, Shenoy S, Baliga S (2007). Candida biofilms in medical devices: Evolving trends. Kathmandu Univ. Med. J. 5:431-436. |
|
|
Douglas LJ (2003). Candida biofilms and their role in infection. Trends Microbiol. 11:30-36. |
|
|
Dutta NK, Kumar KA, Mazumdar K, Das-tidar SG (2004). In vitro and in vivo anti mycobacterial activity of anti-inflammatory drug, Diclofenac sodium. Indian J. Exp. Biol. 42(9):922-927. |
|
|
Erb-Downward JR, Noverr MC (2007). Characterization of prostaglandin E2 production by Candida albicans. Infect. Immun. 75:3498-505. |
|
|
Frölich JC (1997). A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci. 18(1):30-34. |
|
|
Garcia-Rodriguez LJ, Valle R, Duran A, Roncero C (2005). Cell integrity signaling activation in response to hyperosmotic shock in yeast. FEBS Lett. 579:6186-6190. |
|
|
Golia S, Hittinahalli V, Sangeetha KT, Vasudha CL (2011). Study of biofilm formation as a virulence marker in Candida species isolated from various clinical specimens. JEMDS 1:1238-1246. |
|
|
Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG (2006). Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: A double-blind multicentre randomized controlled trial. Br. J. Dermatol. 155(4):680-687. |
|
|
Gotz F (2002). Staphylococcus and Biofilms. Mol. Microbiol. 43(6):1367-1378. |
|
|
Hoyer LL (2001). The ALS gene family of Candida albicans. Trends Microbiol. 9:176-180. |
|
|
Ji G, Beavis RC, Novick RP (1995). Cell Density Control of Staphylococcal Virulence Mediated by an Octa- peptide Pheromone. Proc. Natl. Acad. Sci. USA 92(26):12055-12059. |
|
|
Klotz SA, Chasin B (2007). Powell B, Gaur NK, Lipke PN. Polymicrobial bloodstream infections involving Candida species: Analysis of patients and review of the literature. Diagn. Microbiol. Infect. Dis. 59(4):401-406. |
|
|
Kojic EM, Darouiche RO (2004). Candida infections of medical devices. Clin. Microbiol. Rev. 17:255-267. |
|
|
Liu H, Kohler J, Fink GR (1994). Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266: 1723-1726. |
|
|
Loza L, Fu Y, Ibrahim AS, Sheppard DC, Filler SG, Edwards JE (2004). Functional analysis of the Candida albicans ALS1 gene product. Yeast 21(6):473-482. |
|
|
Mishra NN, Ali S, Shukla PK (2014). Arachidonic acid affects biofilm formation and PGE2 level in Candida albicans and non-albicans species in presence of sub-inhibitory concentration of fluconazole and terbinafine. Braz. J. Infect. Dis. 18(3):287-293. |
|
|
Mohsen A, Gomaa A, Mohamed F, Ragab R, Eid M, Ahmed A, Khalaf A. (2015). Antibacterial, Anti-biofilm Activity of Some Non-steroidal Anti-Inflammatory Drugs and N-acetyl Cysteine against Some Biofilm Producing Uropathogens. Am. J. Epidemiol. Infect. Dis. 1:1-9. |
|
|
Niazi S, Javali C, Paramesh M, Shivaraja S (2010). Study of influence of linkers and substitutions on antimicrobial activity of some Schiff bases. Int. J. Pharm. Pharm. Sci. 2:108-112 |
|
|
O'Gara JP (2007). ICA and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol. Lett. 270(2):179-188. |
|
|
Paniagua-Contreras G, Sáinz-Espu-es T, Monroy-Pérez E, Raymundo J R, Arenas-Aranda D, Negrete-Abascal E, Vaca S (2012). Virulence Markers in Staphylococcus aureus strains isolated from hemodialysis catheters of Mexican patients. Adv. Microbiol. 2(4):476-487. |
|
|
Parker MG, Doebbeling BN (2012). The challenge of Methicillin-resistant Staphylococcus aureus prevention in hemodialysis therapy. Semin. Dial. 25(1):42-49. |
|
|
Pfaller MA, Diekma DJ (2007). Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev. 20:133-163. |
|
|
Pina-Vaz C, Sansonetty F, Rodrigues AG, Martinez-De-Oliveira J, Fonseca AF, Mardh PA (2000). Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species. J. Med. Microbiol. 49:831-840. |
|
|
Scheinman RI, Cogswell PC, Lofquist AK, Baldwin ASJ (1995). Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283-286. |
|
|
Seo YS, Lee DY, Rayamahji N, Kang ML, Yoo HS (2008). Biofilm-forming associated genotypic and phenotypic characteristics of Staphylococcus spp. Isolated from animals and air. Res. Vet. Sci. 85(3):433-438. |
|
|
Viale P, Stefani S (2006). Vascular Catheter-Associated Infections: A Microbiological and Therapeutic Update. J. Chemother. 18(3):235- 249. |
|
|
Wang JD, Douville NJ, Takayama S, Elsayed M (2012). Quantitative Analysis of Molecular Absorption into PDMS Microfluidic Channels. Ann. Biomed. Eng 40(9):1862-1873 |
|
|
Wei GX, Campagna AN, Bokek LA (2006). Effect of MUC7 Peptides on the growth of bacteria and on Streptococcus mutans biofilm. J. Antimicrob. Agents 57:1100-1109. |
|
|
Zhou Y, Wang G, Li Y, Liu Y, Song Y, Zheng W, Zhang N, Hu X, Yan S, Jia J (2012). In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of C. albicans and C. parapsilosis. Antimicrob. Agents Chemother. 56:2350-2360. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
